REQUEST A DEMO
Total
USD $0.00
Search more companies

Product Development Pharma Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Food Manufacturing
Secondary Activities: All Other Food Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Product Development Pharma Sp. z o.o. Profile Updated: April 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Product Development Pharma Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise currently operates in the All Other Miscellaneous Food Manufacturing sector. It was first established on January 18, 2021. Its’ total assets recorded a negative growth of 35.21%.

Headquarters
Ul. Twarda 18
Warsaw; Mazowieckie; Postal Code: 00-105

Contact Details: Purchase the Product Development Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Product Development Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Product Development Pharma Sp. z o.o. report to view the information.
Incorporation Date:
January 18, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Product Development Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-34.98%
Net Profit (Loss) for the Period
-42.03%
Total assets
-35.21%
Total equity
-23.92%
Return on Equity (ROE)
8.31%
Debt to Equity Ratio
26.97%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?